Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
7 trials
Recent
Start date
Enrollment
Phase 1/2
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
lenvatinib
×
Clear all
Filters
3
NCT04938817
2026-03-19
KEYNOTE-B98
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
110 enrolled
NCT05319730
2026-03-02
MK-3475-06B
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
230 enrolled
NCT04626479
2026-02-12
MK-3475-03A
Merck Sharp & Dohme LLC
Phase 1/2
Active not recruiting
400 enrolled
NCT04700072
2025-10-28
KEYMAKER-U02
Merck Sharp & Dohme LLC
Phase 1/2
Completed
56 enrolled
NCT04305041
2025-08-29
KEYMAKER-U02
Merck Sharp & Dohme LLC
Phase 1/2
Completed
100 enrolled
NCT04305054
2025-08-29
KEYMAKER-U02
Merck Sharp & Dohme LLC
Phase 1/2
Active not recruiting
315 enrolled
NCT04626518
2025-07-25
KEYMAKER-U03
Merck Sharp & Dohme LLC
Phase 1/2
Active not recruiting
370 enrolled